David van Duin
banner
davidvanduin.bsky.social
David van Duin
@davidvanduin.bsky.social
Infectious Diseases physician, transplant infectious diseases, antimicrobial resistance. University of North Carolina at Chapel Hill. EiC for JAC-AMR https://academic.oup.com/jacamr. #IDsky #TxID
Looking forward to UNC Institute of Global Health and Infectious Diseases Friday talk globalhealth.unc.edu/education/fr...
October 31, 2025 at 1:15 PM
Dr Cesar Arias delivers Maxwell Finland Lecture #IDweek2025
“Antimicrobials save the patient and reduce infectiousness”
“My research comes from a question in one patient”

💯
October 21, 2025 at 1:41 PM
Dr Yohei Doi now introducing Dr. Cesar Arias as the Maxwell Finland lecturer. #IDWeek2025

A pioneer in AMR research 🤩
October 21, 2025 at 1:37 PM
Dr Tamma: Susceptibility for cefuroxime, cefoodoxime, cefdinir, cefixime looking encouraging in ceftriaxone-susceptible Enterobacterales from BSI at Hopkins.
#IDweek2025 #IDsky

pubmed.ncbi.nlm.nih.gov/39745384/
October 19, 2025 at 6:55 PM
Dr Tamma mentions the ongoing GOAT trial (PI Tamma & Cosgrove)
This will be a most needed and important study. clinicaltrials.gov/study/NCT060...
#IDweek2025 #IDsky
October 19, 2025 at 6:46 PM
Dr Molina now discusses the important ARLG study DOTS.
Primary outcome was a desirability of outcome ranking analysis
Similar in dalba vs SOC
#idweek2025 #idsky
October 19, 2025 at 6:24 PM
Curious about new antibacterials in the pipeline? Check out Monday 8am session in B302 and be (among) the first to know.
#IDweek2025 #IDsky
October 19, 2025 at 6:16 PM
Dr. Molina now summarizing data on the use of long-acting anti-gram-positive bacterial agents: dalbavancin, and oritavancin
#IDweek2025 #IDsky
October 19, 2025 at 6:11 PM
#IDWeek2025 let’s go!
#IDsky
October 19, 2025 at 5:30 PM
@yhgrad.bsky.social giving a great talk on AMR in N. gonorrhoea. Asking the question of best rollout of new drugs. Modeling suggest better not to hold new drugs in reserve #AMRsky #IDsky
November 22, 2024 at 2:39 PM